Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,141 public trials 305 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)

NCT03292406

Conditions
Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Galderma Investigational Site Orange, California, United States
  • Galderma Investigational Site Palo Alto, California, United States
  • Galderma Investigational Site Farmington, Connecticut, United States
  • Galderma Investigational Site Chicago, Illinois, United States
View all 21 locations
View Trial Details
Completed

Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma

NCT00278421

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +21 more
Locations
  • Haematologisch Onkologische Praxis Aachen, Germany
  • Klinikum Augsburg Augsburg, Germany
  • Klinikum Bayreuth Bayreuth, Germany
  • Haematologisch-Onkologische Schwerpunktpraxis - Weilheim Berlin, Germany
View all 78 locations
View Trial Details
Completed

Ibrutinib With Rituximab in Adults With Waldenström's Macroglobulinemia

NCT02165397

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Stanford Cancer Center Palo Alto, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Emory University Hospital Atlanta, Georgia, United States
View all 48 locations
View Trial Details
Completed

Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)

NCT01327612

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +44 more
Locations
  • Research Site Duarte, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Tampa, Florida, United States
View Trial Details
Completed

Phase I/Ib Study of GWN323 Alone and in Combination With PDR001 in Patients With Advanced Malignancies and Lymphomas

NCT02740270

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Novartis Investigative Site Chicago, Illinois, United States
  • Novartis Investigative Site Boston, Massachusetts, United States
  • Novartis Investigative Site New York, United States
  • Novartis Investigative Site Houston, Texas, United States
View Trial Details

Related conditions